Methods For Diagnosing Cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 3, 2014
app pub date -
Mar 7, 2014
filing date -
Sep 8, 2011
priority date (Note) -
Abandoned
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Abstract
Methods and kits for the detection of cancer and for pre-cancer screening based on the expression of genes associated with altered metabolism and apoptosis in cancerous cells, particularly the expression of a mitochondrial antiviral-signaling (MAVS) or a voltage-dependent anion channel 1 (VDAC1) protein or mRNA in combination with additional genes associated with cell metabolism and/or apoptosis.
First Claim
all claims..Other Claims data not available
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY | P O BOX 653 84105 BEER-SHEVA ISRAEL | |
THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD | BEN-GURION UNIVERSITY OF THE NEGEV P O BOX 653 BEER SHEVA 8410501 |
International Classification(s)

- 2014 Application Filing Year
- C12Q Class
- 3114 Applications Filed
- 2141 Patents Issued To-Date
- 68.76 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Shoshan-Barmatz, Varda | Omer, IL | 31 | 26 |
# of filed Patents : 31 Total Citations : 26 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 1 Citation Count
- C12Q Class
- 20.93 % this patent is cited more than
- 11 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|---|---|---|---|
11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Jan 3, 2026 |
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
Date | Code | Event | Description |
---|---|---|---|
Mar 14, 2013 | FPAY | FEE PAYMENT | year of fee payment: 12 |
May 25, 2009 | FPAY | FEE PAYMENT | year of fee payment: 8 |
May 27, 2005 | FPAY | FEE PAYMENT | year of fee payment: 4 |
Dec 04, 2001 | I | Issuance | |
Nov 16, 2001 | STCF | INFORMATION ON STATUS: PATENT GRANT | free format text: PATENTED CASE |
Feb 14, 2000 | F | Filing | |
Dec 03, 1999 | AS | ASSIGNMENT | free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ANDRE, JEAN-FRANCOIS;REEL/FRAME:010570/0788 Owner name: FCB SOCIETE ANONYME, FRANCE Effective Date: Dec 03, 1999 |
Jun 30, 1997 | PD | Priority Date |

Matter Detail

Renewals Detail
